Once Daily Immunosuppression Regimen

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to determine whether an immunosuppressive maintenance regimen of Envarsus/azathioprine compared to a tacrolimus/ mycophenolic acid regimen is associated with better compliance, tolerability, and lower biopsy proven rejection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborator: Veloxis Pharmaceuticals

Criteria

Inclusion Criteria:

• Age >/= 18 years old

• Kidney transplant recipient

• Thymoglobulin induction

Exclusion Criteria:

• Non-renal organ transplant

• Combined organ transplant

• Inability to receive Envarsus after transplant

• Discharged to acute care facility after transplant